Your browser doesn't support javascript.
loading
Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system.
Creinin, Mitchell D; Jansen, Rolf; Starr, Robert M; Gobburu, Joga; Gopalakrishnan, Mathangi; Olariu, Andrea.
Affiliation
  • Creinin MD; Department of Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA. Electronic address: mdcreinin@ucdavis.edu.
  • Jansen R; Medicines360, San Francisco, CA, USA.
  • Starr RM; Medicines360, San Francisco, CA, USA.
  • Gobburu J; University of Maryland School of Pharmacy, Baltimore, MD, USA.
  • Gopalakrishnan M; University of Maryland School of Pharmacy, Baltimore, MD, USA.
  • Olariu A; Medicines360, San Francisco, CA, USA.
Contraception ; 94(4): 353-6, 2016 10.
Article in En | MEDLINE | ID: mdl-27125892
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Levonorgestrel / Contraceptive Agents, Female Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: Contraception Year: 2016 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Levonorgestrel / Contraceptive Agents, Female Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: Contraception Year: 2016 Document type: Article Country of publication: United States